Target intelligence / Profile preview

T cell receptor gamma locus (TRG)

Target
TRG
Molecular classification
Gene locus, Diagnostic biomarker
01

Overview

The T cell receptor gamma gene (TRG) locus encodes the gamma chain component of the T-cell receptor, an essential component of the adaptive immune system. During normal T-cell development, the TRG locus undergoes somatic V(D)J recombination, a process in which variable and joining gene segments combine to create diverse T-cell receptors capable of recognizing countless antigens. TRG gene rearrangement analysis is not a therapeutic drug target; rather, it serves as a critical diagnostic biomarker for detecting clonal T-cell populations. In T-cell lymphomas and leukemias, malignant transformation produces monoclonal T-cells with identical TRG rearrangement profiles, whereas normal immune systems maintain polyclonal diversity. Molecular testing using PCR and fragment analysis detects these rearrangement patterns in blood, bone marrow, or tissue, helping clinicians diagnose T-cell malignancies and monitor treatment response.

Other names
T cell receptor gamma locusTCR-γ geneTCRG geneTRG@
02

Mechanism of action

Not applicable for drugs. However, the molecular mechanism underlying TRG rearrangement involves: - V(D)J recombination mediated by RAG1 and RAG2 enzymes (lymphoid-specific recombinase) - Recombination signal sequences (RSS) flanking gene segments that direct the recombination process - Addition of P- and N-nucleotides at junctional regions, creating diversity

03

Biological functions

Antigen recognition: The γ chain (along with δ, β, or α chains) forms part of the T-cell receptor heterodimer on the cell surfaceImmune response: Contributes to T-cell mediated immunityLymphocyte development: Gene rearrangement occurs as part of normal T and B lymphocyte maturation
04

Disease associations

Cancer (lymphoma, leukemia)Diagnostic/prognostic application
05

Safety considerations

Test sensitivity/specificity limitations: Some T-cell lymphomas may not show detectable clonal rearrangements; conversely, some non-malignant conditions show clonal patternsFalse positives: Illegitimate TCR-γ gene rearrangement can occur in B-cell lymphomas (~12% in some studies), requiring careful interpretation
06

Biomarkers

Polyclonal pattern: Indicates normal, diverse T-cell populationMonoclonal/clonal pattern: Indicates malignant T-cell clone; suggests T-cell lymphoma or leukemiaOligoclonal pattern: Indicates limited T-cell clones; may suggest early neoplasia or immune dysfunction

Beyond the preview

Go deeper on T cell receptor gamma locus (TRG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor gamma locus (TRG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call